EC Healthcare has issued a profit warning for the six months ended 30 September 2025. Based on preliminary unaudited consolidated management accounts, the company expects its revenue for the reporting period to decrease by no more than 10% compared to approximately HK$2,062.9 million for the same period in 2024. The decline in financial results is attributed to weak local consumption sentiment, increased spending by Hong Kong residents on medical and wellness services in Mainland China, higher outbound travel, the absence of revenue from previously disposed medical assets, a less favourable service mix, and reduced operating leverage from lower revenue. The company noted that its overall balance sheet remains strong, with a solid position in cash, time deposits, and current financial assets. The official consolidated results for the period are expected to be released on 28 November 2025. Shareholders and potential investors are advised to exercise caution when dealing in the company's shares.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EC Healthcare published the original content used to generate this news brief via via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251124-11926138), on November 24, 2025, and is solely responsible for the information contained therein.
Comments